Comparison of Biomarkers to Differentiate Chronic Kidney Disease and Chronic Kidney Disease of Unknown Etiology
Life Sciences-Biochemistry
DOI:
https://doi.org/10.22376/ijpbs/lpr.2022.12.5.L40-48Keywords:
Biomarkers, Chronic kidney disease of unknown etiology, Kidney injury molecule-1, Neutrophil gelatinaseassociated lipocalin.Abstract
Chronic kidney disease of unknown etiology (CKDU) is prevalent and clinically silent until its late stages at which patient may suffer significant irreversible damage, or mortality in the absence of early screening and intervention. CKDU is asymptomatic but may show nonspecific symptoms. Conventional markers are influenced by multiple non-renal factors while Kidney injury molecule-1(KIM-1) and Neutrophil gelatinase-associated lipocalin(NGAL) are promising biomarkers of chronic kidney disease (CKD), there are no studies reported so far on these markers in CKDU. The aim of the study is to assess the sensitivity of biomarkers serum KIM-1 and NGAL in patients with CKDU in comparison with CKD and controls. To achieve this, our objectives are to estimate the level of biochemical parameters like serum creatinine, urea, uric acid, random blood sugar, systolic and diastolic blood pressure and hemoglobin and to compare novel biomarkers KIM-1 and NGAL in CKDU patients with CKD. The serum levels of urea, uric acid, creatinine, KIM-1 and NGAL were estimated in control, CKD and CKDU (n = 35, 46, 79 respectively). Creatinine showed 8.1-fold and 2.7-fold increase (P <0.001), and urea 4.0% and 1.8% increase (P < 0.001), compared to control in CKD and CKDU cohorts, respectively. The sensitivity and specificity of KIM-1 was 73.4% and 67.4%with a cutoff value of 203.5ng/mL using the receiver operating characteristic(ROC) curve. For NGAL they were 82.3%, 73.9% and 255ng/mL. Compared to control, KIM-1 showed a 51.5-fold and 87.2-fold increase in CKD and CKDU, respectively (P < 0.001). NGAL showed a 4.8-fold and 6.7-fold increase in CKD and CKDU, respectively (P < 0.001). Creatinine and urea were higher in CKD than in CKDU, whereas KIM-1 and NGAL were higher in CKDU than CKD. KIM-1 and NGAL are sensitive biomarkers for CKDU. KIM-1 can differentiate CKD and CKDU.
References
Thapa L, Karki P, Sharma SK, Bajaj BK. Cardiovascular autonomic neuropathy in chronic kidney diseases. JNMA J Nepal Med Assoc. 2010 Apr-Jun;49(178):121-8. PMID 21485597.
Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662-4. doi: 10.1016/S0140-6736(19)32977-0, PMID 32061314.
Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013 Jul 20;382(9888):260-72. doi: 10.1016/S0140-6736(13)60687-X, PMID 23727169.
Ganguli A. Uddanam nephropathy/regional nephropathy in India: preliminary findings and a plea for further research. Am J Kidney Dis. 2016 Sep;68(3):344-8. doi: 10.1053/j.ajkd.2016.04.012, PMID 27209444.
Weaver VM, Fadrowski JJ, Jaar BG. Global dimensions of chronic kidney disease of unknown etiology (CKDu): a modern era environmental and/or occupational nephropathy? BMC Nephrol. 2015 Aug 19;16(1):145-52. doi: 10.1186/s12882-015-0105-6.
Redmon JH, Elledge MF, Womack DS, Wickremashinghe R, Wanigasuriya KP, Peiris-John RJ et al. Additional perspectives on chronic kidney disease of unknown aetiology (CKDu) in Sri Lanka--lessons learned from the WHO CKDu population prevalence study. BMC Nephrol. 2014 Jul 28;15:125. doi: 10.1186/1471-2369-15-125, PMID 25069485.
Tatapudi RR, Rentala S, Gullipalli P, Komarraju AL, Singh AK, Tatapudi VS et al. High prevalence of CKD of unknown etiology in Uddanam, India. Kidney Int Rep. 2019;4(3):380-9. doi: 10.1016/j.ekir.2018.10.006, PMID 30899865.
Rysz J, Gluba-Brzózka A, Franczyk B, Jabłonowski Z, Ciałkowska-Rysz A. Novel biomarkers in the diagnosis of chronic kidney disease and the prediction of its outcome. Int J Mol Sci. 2017 Aug 4;18(8):1702-18. doi: 10.3390/ijms18081702, PMID 28777303.
Khan Z, Pandey M. Role of kidney biomarkers of chronic kidney disease: an update. Saudi J Biol Sci. 2014 Sep;21(4):294-9. doi: 10.1016/j.sjbs.2014.07.003, PMID 25183938.
Fassett RG, Venuthurupalli SK, Gobe GC, Coombes JS, Cooper MA, Hoy WE. Biomarkers in chronic kidney disease: a review. Kidney Int. 2011 Oct;80(8):806-21. doi: 10.1038/ki.2011.198, PMID 21697815.
Wu Y, Su T, Yang L, Zhu SN, Li XM. Urinary neutrophil gelatinase-associated lipocalin: A potential biomarker for predicting rapid progression of drug-induced chronic tubulointerstitial nephritis. Am J Med Sci. 2010 Jun;339(6):537-42. doi: 10.1097/maj.0b013e3181dd0cb1, PMID 20545012.
Vaidya VS, Ozer JS, Dieterle F, Collings FB, Ramirez V, Troth S et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat Biotechnol. 2010 May;28(5):478-85. doi: 10.1038/nbt.1623, PMID 20458318.
Alderson HV, Ritchie JP, Pagano S, Middleton RJ, Pruijm M, Vuilleumier N et al. The associations of blood kidney injury Molecule-1 and neutrophil gelatinase-associated lipocalin with progression from CKD to ESRD. Clin J Am SocNephrol. 2016 Dec 7;11(12):2141-9. doi: 10.2215/CJN.02670316, PMID 27852662.
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002 Feb;39(2);Suppl 1:S1-266. PMID 11904577.
Hoste L, Deiteren K, Pottel H, Callewaert N, Martens F. Routine serum creatinine measurements: how well do we perform? BMC Nephrol. 2015 Feb 14;16:21. doi: 10.1186/s12882-015-0012-x, PMID 25803560.
Sambenedetto A, Marrama P, Ottavi PF, Castronuovo A. Review of the methods of determination of blood urea with continuous-flow analyzers and a proposal of a completely enzymatic UV method for urea by a continuous-flow analyzer [Review of the methods of determination of blood urea with continuous-flow analyzers and a proposal of a completely enzymatic UV method for urea by a continuous-flow analyzer]. Quad SclavoDiagn. 1982 Dec;18(4):440-6. PMID 7186646.
Sanders GT, Pasman AJ, Hoek FJ. Determination of uric acid with uricase and peroxidase. ClinChimActa. 1980 Feb 28;101(2-3):299-303. doi: 10.1016/0009-8981(80)90257-0, PMID 7357749.
De Silva PM, Mohammed Abdul KS, Eakanayake EM, Jayasinghe SS, Jayasumana C, Asanthi HB et al. Urinary biomarkers KIM-1 and NGAL for detection of chronic kidney disease of uncertain etiology (CKDu) among agricultural communities in Sri Lanka. PLOS Negl Trop Dis. 2016 Sep 19;10(9):e0004979. doi: 10.1371/journal.pntd.0004979, PMID 27643785.
Johnson RJ, Glaser J, Sánchez-Lozada LG. Chronic kidney disease of unknown etiology: a disease related to global warming? MEDICC Rev. 2014 Apr;16(2):79-80. doi: 10.37757/MR2014.V16.N2.15, PMID 24878656.
Roncal Jimenez CA, Ishimoto T, Lanaspa MA, Rivard CJ, Nakagawa T, Ejaz AA et al. Fructokinase activity mediates dehydration-induced renal injury. Kidney Int. 2014 Aug;86(2):294-302. doi: 10.1038/ki.2013.492, PMID 24336030.
Sun IO, Shin SH, Cho AY, Yoon HJ, Chang MY, Lee KY. Clinical significance of NGAL and KIM-1 for acute kidney injury in patients with scrub typhus. PLOS ONE. 2017 Apr 18;12(4):e0175890. doi: 10.1371/journal.pone.0175890, PMID 28419138.
Wine arls CG, Speeckaert M, Langhe JD. Oxford textbook of clinical nephrology. 4th ed. Oxford University Press; 2015. p. 1-5.
Johnson RJ, John FJ. Floege. Comprehensive clinical nephrology. 5th ed. Elsevier; 2015. p. 30-5.
Baysoy A, Karakoyun I, Arslan FD, Basok BI, Colak A, Duman C. Biological variation data for kidney function related parameter: serum beta trace protein, creatinine and cystatin C from 22 apparently healthyTurkish subjects. ClinChem Lab Med. 2022;60(4):465-468:584-92 9. doi: 10.1515/cclm-2021-0543, PMID 34506692.
Abuşoğlu S, Aydın İ, Bakar F, Bekdemir T, GülbaharÖ, İşlekel H, et al. A short guideline on chronic kidney disease for medical laboratory practice. Turk J Biochem. 2016 Aug 2;41(4):292-301.
Korecki KS, Chertow GM. Brenner& Rector’s the kidney. 10th ed. Elsevier; 2016. p. 782-83.
Seki M, Nakayama M, Sakoh T, Yoshitomi R, Fukui A, Katafuchi E et al. Blood urea nitrogen is independently associated with renal outcomes in Japanese patients with stage 3-5 chronic kidney disease: a prospective observational study. BMC Nephrol. 2019 Apr 2;20(1):115. doi: 10.1186/s12882-019-1306-1, PMID 30940101.
Toyama T, Furuichi K, Shimizu M, Hara A, Iwata Y, Sakai N et al. Relationship between serum uric acid levels and chronic kidney disease in a Japanese cohort with normal or mildly reduced kidney function. PLOS ONE. 2015 Sep 10;10(9):e0137449. doi: 10.1371/journal.pone.0137449, PMID 26356235.
Smith ER, Lee D, Cai MM, Tomlinson LA, Ford ML, McMahon LP et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant. 2013 Jun;28(6):1569-79. doi: 10.1093/ndt/gfs586, PMID 23328709.
Anupama YJ, Kiran SK, Hegde SN. Heavy metals and pesticides in chronic kidney disease - results from a matched case-control study from a rural population in Shivamogga District in South India. Indian J Nephrol. 2019 Nov-Dec;29(6):402-9. doi: 10.4103/ijn.IJN_325_18, PMID 31798222.
Bagshaw SM, Gibney RT. Conventional markers of kidney function. Crit Care Med. 2008 Apr;36(4);Suppl:S152-8. doi: 10.1097/CCM.0b013e318168c613, PMID 18382187.
Ratnayake S, Badurdeen Z, Nanayakkara N, Abeysekara T, Ratnatunga N, Kumarasiri R. Screening for chronic kidney disease of uncertain aetiology in Sri Lanka: usability of surrogate biomarkers over dipstick proteinuria. BMC Nephrol. 2017 Jun 19;18(1):199. doi: 10.1186/s12882-017-0610-x, PMID 28629425.
Wanigasuriya K, Jayawardene I, Amarasiriwardena C, Wickremasinghe R. Novel urinary biomarkers and their association with urinary heavy metals in chronic kidney disease of unknown aetiology in Sri Lanka: a pilot study. Ceylon Med J. 2017 Dec 26;62(4):210-7. doi: 10.4038/cmj.v62i4.8568, PMID 29390596.
Guo L, Zhu B, Yuan H, Zhao W. Evaluation of serum neutrophil gelatinase-associated lipocalin in older patients with chronic kidney disease. Aging Med (Milton). 2020 Mar 27;3(1):32-9. doi: 10.1002/agm2.12098, PMID 32232190.
Ozyurt S, Karatas M, Arpa M, Yilmaz Kara B, Duman H, Memoglu M, et al. Neutrophil gelatinase-associated lipocalin as a potential biomarker for pulmonary thromboembolism. Turk J Biochem. 2020 Oct 12;45(1):51-6. doi: 10.1515/tjb-2018-0308.
Yerramilli M, Farace G, Quinn J, Yerramilli M. Kidney disease and the nexus of chronic kidney disease and acute kidney injury: the role of novel biomarkers as early and accurate diagnostics. Vet Clin North Am Small AnimPract. 2016 Nov;46(6):961-93. doi: 10.1016/j.cvsm.2016.06.011, PMID 27485279.
Published
How to Cite
Issue
Section
Copyright (c) 2022 Nakka Rajyalakshmi, Vijayaraghavan Rajagopalan, Senthilkumar Sivanesan, Vijaya Sabhavatu
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
